Ontology highlight
ABSTRACT: Background
The role of induction in low-risk, living-donor kidney transplants being treated with tacrolimus, mycophenolate mofetil, and prednisolone is debatable.Materials and methods
This was a retrospective study that consisted of patients undergoing living kidney transplantation between February 2010 and June 2021 with a related haplomatch donor, with maintenance immunosuppression of tacrolimus, mycophenolate mofetil, and prednisolone. High-risk transplants, such as second or more transplants, immunologically incompatible transplants, and steroid-free transplants, were excluded. Patients were divided into three groups: no induction, basiliximab induction, and thymoglobulin induction, and the outcomes of all three were compared.Results
A total of 350 transplants w
SUBMITTER: Jha PK
PROVIDER: S-EPMC11302600 | biostudies-literature | 2024 May-Jun
REPOSITORIES: biostudies-literature